Hansen Katherine, Grady Stafford, McCrindle Brian W, Harahsheh Ashraf S, Elias Matthew D, Dahdah Nagib, Selamet Tierney Elif Seda
Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Division of Cardiology, Department of Pediatrics, University of Toronto, Labatt Family Heart Center, The Hospital for Sick Children, Toronto, ON, Canada.
Pediatr Cardiol. 2023 Mar;44(3):631-639. doi: 10.1007/s00246-022-02984-z. Epub 2022 Aug 11.
Recommendations for management of patients with Kawasaki disease (KD) and coronary artery aneurysms (CAA) include physical activity (PA) promotion. This study aimed to characterize self-reported practices of KD providers to evaluate practice variation in use of cardiopulmonary exercise testing (CPET) and PA recommendations. We developed a REDCap survey with different clinical scenarios of KD patients. It was completed by members of the International Kawasaki Disease Registry (IKDR) and community pediatric cardiologists. Twenty-eight physicians responded; 63% practiced in the US, 63% practiced in an academic setting, 48% were general pediatric cardiologists, and 55% were IKDR members. Most respondents (69%) followed < 50 KD patients. The great majority (93%) agreed that patients with no CAA do not require CPET and could be cleared for all PA. For patients with small CAA, 43% of respondents recommended CPET and 75% cleared for all PA if CAAs regressed completely, but only 32% cleared if CAA persisted. For patients with medium CAA, 66% respondents cleared for PA if CAA regressed, and only 7% if CAA persisted; with 66% and 75% recommending CPET, respectively. For patients with large/giant CAA, 81% of respondents recommended CPET. No respondents felt comfortable clearing their patients with persistent large/giant CAA for PA and 19% would restrict from the entire physical education program. There is practice variation in use of CPET in KD patients with CAAs. Providers are hesitant to promote PA in KD patients with CAA despite known benefits and current guidelines.
川崎病(KD)和冠状动脉瘤(CAA)患者的管理建议包括促进身体活动(PA)。本研究旨在描述KD医护人员自我报告的做法,以评估心肺运动试验(CPET)使用和PA建议方面的实践差异。我们针对KD患者的不同临床情况开发了一项REDCap调查。国际川崎病注册中心(IKDR)成员和社区儿科心脏病专家完成了该调查。28名医生做出了回应;63%在美国执业,63%在学术机构执业,48%是普通儿科心脏病专家,55%是IKDR成员。大多数受访者(69%)随访的KD患者少于50例。绝大多数(93%)同意无CAA的患者不需要CPET,并且可以进行所有PA。对于小CAA患者,43%的受访者建议进行CPET,75%认为如果CAA完全消退可进行所有PA,但如果CAA持续存在,只有32%的受访者认为可进行PA。对于中CAA患者,如果CAA消退,66%的受访者认为可进行PA,如果CAA持续存在,只有7%的受访者认为可进行PA;分别有66%和75%的受访者建议进行CPET。对于大/巨大CAA患者,81%的受访者建议进行CPET。没有受访者愿意让患有持续性大/巨大CAA的患者进行PA,19%的受访者会禁止其参加整个体育教育项目。在患有CAA的KD患者中,CPET的使用存在实践差异。尽管已知PA有益且有现行指南,但医护人员仍对促进患有CAA的KD患者进行PA持犹豫态度。